ASX
AdAlta Limited
1AD:ASX•Healthcare
Sensitive ASX Announcement
1AD & GPCR Therapeutics to evaluate CXCR4 i-bodies in cancer
Published: 13/10/22, 08:19am (AEST)•4 pages